Clinical Trial

Beta-Blocker Influences on Inflammatory and Neural Responses to Stress

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated October 29, 2025 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to map the neural and molecular mechanisms underlying psychological stress-induced changes in inflammation which could reveal new targets for intervention to reduce the risk of cardiovascular disease.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-02-08; most recent amendment 2025-10-27.
Status change: Not Yet Recruiting → Recruiting 2024-05-07
Trial Details
NCT Number NCT06263452
Lead Sponsor University of North Carolina, Chapel Hill
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), University of California, Los Angeles, Dartmouth College
Conditions Cardiovascular Disease
Enrollment 120 participants
Start Date 2024-05-01
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2025-10-29